How many institutions own SNSE stock?

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own SNSE shares is 12, representing 4.04% of the company's common stock.

Who are the major shareholders selling Sensei Biotherapeutics, Inc. stock?

JPMORGAN CHASE & CO, in the last quarter, reduced its stake in SNSE by -0.43% restricting it's holding to 702 shares of worth nearly $276.00. TOWER RESEARCH CAPITAL LLC (TRC) also lessened -0.81% of the SNSE shares from its portfolio, reducing its holding to 5.4 thousand shares of worth $2.13K. IKARIAN CAPITAL, LLC also shunned SNSE shares holding by -30.77% last quarter which brought its holding to 449.96 thousand shares worth $177.29K.

Investors who are buying SNSE stock?

As per its latest 13F filing, SBI SECURITIES CO., LTD. increased its stake in SNSE by 29.58% in the last quarter. The institutional holder raised its holding to 92 shares having worth more than $36.00. BARCLAYS PLC also added 100% more shares of SNSE to its portfolio, raising its holding to 2.56 thousand shares of worth $1.00K. RENAISSANCE TECHNOLOGIES LLC also increased its SNSE shares holding by 13.07% which brought its holding to 177.3 thousand shares worth $69.86K.

SNSE's major insiders: who are they?

The insider with the most stakes in SNSE is RICKS THOMAS G , director at the company. Additionally, SNSE stock is highly held by 10 percent owner Cambrian BioPharma Inc and See remarks below Peyer James among others.

Did an insider recently sell SNSE stock?

Company executives, directors, and other insiders own 32.08% percent of Sensei Biotherapeutics, Inc.'s stock. Within the last six months, there have been 7 transaction(s) in which SNSE insiders have sold stock, totaling 14.08K shares. Insiders that have sold shares include CAMBRIAN BIOPHARMA INC, PEYER JAMES, and APEIRON INVESTMENT GROUP LTD..

Which insider recently purchased SNSE stock?

There have been 0 transaction(s) during the past 6-months in which Sensei Biotherapeutics, Inc. insiders have bought stock, totalling 0 shares

How much of SNSE does insiders own?

Around 1.15M Sensei Biotherapeutics, Inc. shares are held by insiders, which represents about 32.08% of SNSE stock.

Who is the insider with the largest stake?

SNSE director, RICKS THOMAS G holds the largest portfolio of the company's shares. SNSE shares owned by RICKS total nearly 341.77 thousand.

Which institution holds the most shares in SNSE?

SBI SECURITIES CO., LTD. is the largest institutional owner in SNSE which holds 92 shares worth $36.00 or 0% of the total SNSE shares outstanding followed by BNP PARIBAS ARBITRAGE, SNC with ownership of 160 shares representing 0% of the SNSE ownership. JPMORGAN CHASE & CO is the third largest stakeholder with 702 shares or 0% of the ownership worth more than $276.00.

Is Sensei Biotherapeutics, Inc. stock optionable?

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the SNSE is concerned, it is a stock which is not optionable.

Is there a short position on SNSE's shares?

Number of SNSE shares short is 7.93K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

About how many outstanding SNSE shares are there?

As of today, 1.26M shares of SNSE are outstanding.

Is there many float in SNSE stock?

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, SNSE has 828.30K shares in float.

SNSE short ratio: what is it?

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for SNSE is 0.76.

Sensei Biotherapeutics (SNSE) insider trading activity: Get Latest News Today

Stock Outstanding Shares

Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.

ShortableYes

OptionableNo

Short Percent Of Outstanding Shares0.63

Short Percent Of Float0.94

Shares Outstanding1.26M

Shares Float828.30K

Shares Short7.93K

Short Ratio0.76

0.94%

Short % of Float

0.63%

Short % of Shares Outstanding

Market Insider

Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.

Major Holders Summary

32.08% Percentage of Shares held by All Insiders

4.04% Percentage of Shares held by All Institutions

5.96% Percentage of Float held by Institutions

Number of Institutions Holding Shares

Institutional Ownership

About 4.04% of SNSE shares are held by financial institutions. SBI SECURITIES CO., LTD. is the top corporate investor, holding 92 shares valued at $36.00. A 0% stake in Sensei Biotherapeutics, Inc. is owned by the company. BNP PARIBAS ARBITRAGE, SNC owns 160 shares valued at $63.00, which translates its holding of 0% of the stake in the company.

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Mar 31, 2025	SBI SECURITIES CO., LTD.	0%	92	36	21	+29.58%
Mar 31, 2025	BNP PARIBAS ARBITRAGE, SNC	0%	160	63	0	0
Mar 31, 2025	JPMORGAN CHASE & CO	0%	702	276	-3	-0.43%
Mar 31, 2025	BARCLAYS PLC	0.01%	2.56K	1K	2.56K	+100.00%
Mar 31, 2025	TOWER RESEARCH CAPITAL LLC (TRC)	0.02%	5.4K	2.13K	-44	-0.81%
Mar 31, 2025	MORGAN STANLEY	0.04%	9.22K	3.63K	0	0
Mar 31, 2025	RENAISSANCE TECHNOLOGIES LLC	0.7%	177.3K	69.86K	20.5K	+13.07%
Mar 31, 2025	IKARIAN CAPITAL, LLC	1.79%	449.96K	177.29K	-200K	-30.77%
Mar 31, 2025	DEUTERIUM CAPITAL MANAGEMENT, LLC	0%	0	-	-11K	-100.00%
Mar 31, 2025	XTX TOPCO LTD	0%	0	-	-62.9K	-100.00%
Mar 31, 2025	NWF ADVISORY SERVICES INC.	0%	0	-	-16.51K	-100.00%
Mar 31, 2025	SUSQUEHANNA INTERNATIONAL GROUP, LLP	0%	0	-	-38.05K	-100.00%
Mar 31, 2025	CITIGROUP INC	0%	124	49	124	+100.00%
Mar 31, 2025	BANK OF AMERICA CORP /DE/	0%	142	56	6	+4.41%
Mar 31, 2025	RAYMOND JAMES FINANCIAL INC	0.06%	14K	5.52K	0	0
Mar 31, 2025	CRESSET ASSET MANAGEMENT, LLC	0.08%	19.67K	7.75K	0	0
Mar 31, 2025	STATE STREET CORP	0.1%	25.77K	10.16K	0	0
Mar 31, 2025	NORTHERN TRUST CORP	0.1%	25.98K	10.24K	0	0
Mar 31, 2025	UBS GROUP AG	0.17%	42.54K	16.76K	42.54K	+2,126,950.00%
Mar 31, 2025	BOOTHBAY FUND MANAGEMENT, LLC	0.43%	108.66K	42.81K	-64.14K	-37.12%
Mar 31, 2025	GEODE CAPITAL MANAGEMENT, LLC	0.6%	150.71K	59.39K	1.82K	+1.22%
Mar 31, 2025	HRT FINANCIAL LP	0%	0	-	-11.6K	-100.00%
Mar 31, 2025		0%	0	-	-16.51K	-100.00%
Mar 31, 2025	VANGUARD GROUP INC	2.32%	585.58K	230.72K	-8.88K	-1.49%
Mar 31, 2025	CATALIO CAPITAL MANAGEMENT, LP	1.17%	294.37K	115.98K	0	0
Mar 31, 2025	CITADEL ADVISORS LLC	0%	0	-	-57.72K	-100.00%
Mar 31, 2025	BRIDGEWAY CAPITAL MANAGEMENT, LLC	0%	0	-	-47.9K	-100.00%
Mar 31, 2024	QUBE RESEARCH & TECHNOLOGIES LTD	0%	4	4	0	0
Mar 31, 2024	BRIDGEWAY CAPITAL MANAGEMENT, LLC	0.4%	112.9K	118.55K	0	0
Mar 31, 2024	BANK OF AMERICA CORP /DE/	0.32%	90.76K	95.3K	-25	-0.03%
Mar 31, 2024	MILLENNIUM MANAGEMENT LLC	0.12%	32.59K	34.22K	-5.71K	-14.91%
Mar 31, 2024	STATE STREET CORP	0.09%	25.77K	27.06K	0	0
Mar 31, 2024	RAYMOND JAMES & ASSOCIATES	0.05%	14K	14.7K	0	0
Mar 31, 2024	RENAISSANCE TECHNOLOGIES LLC	0.75%	211K	222K	67.49K	+47.03%
Mar 31, 2024	GEODE CAPITAL MANAGEMENT, LLC	0.49%	136.32K	143.17K	0	0
Mar 31, 2024	BLACKROCK INC.	0.12%	33.58K	35.26K	-1.23K	-3.54%
Mar 31, 2024	NORTHERN TRUST CORP	0.09%	26.05K	27.35K	0	0
Mar 31, 2024	CRESSET ASSET MANAGEMENT, LLC	0.07%	19.67K	20.66K	19.67K	+100.00%
Mar 31, 2024	TWO SIGMA ADVISERS, LP	0.07%	19K	19.95K	0	0
Mar 31, 2024	NEWTYN MANAGEMENT, LLC	3.33%	930.23K	976.74K	-641.79K	-40.83%
Mar 31, 2024	VANGUARD GROUP INC	2.05%	573.84K	602.54K	193	+0.03%
Mar 31, 2024	CITADEL ADVISORS LLC	0.09%	23.86K	25.06K	-1.94K	-7.51%
Mar 31, 2024	LEO WEALTH, LLC	0.05%	14.85K	15.59K	0	0
Mar 31, 2024	MORGAN STANLEY	0.04%	12.22K	12.83K	12K	+5,479.45%
Mar 31, 2024	DEUTERIUM CAPITAL MANAGEMENT, LLC	0.04%	11K	11.55K	0	0
Mar 31, 2024	TWO SIGMA INVESTMENTS, LP	0.04%	10.18K	10.69K	0	0
Mar 31, 2024	TOWER RESEARCH CAPITAL LLC (TRC)	0.02%	6.71K	7.05K	-1.73K	-20.51%
Mar 31, 2024	BANQUE CANTONALE VAUDOISE	0.01%	3.9K	4K	0	0
Mar 31, 2024	JPMORGAN CHASE & CO	0%	668	701	0	0
Mar 31, 2024	UBS GROUP AG	0%	139	146	139	+100.00%
Mar 31, 2024	WELLS FARGO & COMPANY/MN	0%	133	140	2	+1.53%
Mar 31, 2024	DUQUESNE FAMILY OFFICE LLC	0%	0	-	-100K	-100.00%
Dec 31, 2023	DUQUESNE FAMILY OFFICE LLC	0.39%	100K	69K	0	0
Dec 31, 2023	BRIDGEWAY CAPITAL MANAGEMENT, LLC	0.44%	112.9K	78.13K	0	0
Dec 31, 2023	GEODE CAPITAL MANAGEMENT, LLC	0.53%	136.32K	94.35K	0	0
Dec 31, 2023	RENAISSANCE TECHNOLOGIES LLC	0.56%	143.51K	99K	59.71K	+71.25%
Dec 31, 2023	VANGUARD GROUP INC	2.25%	573.65K	396.97K	0	0
Dec 31, 2023	NEWTYN MANAGEMENT, LLC	6.16%	1.57M	1.09M	-227.98K	-12.67%
Dec 31, 2023	HARBOUR INVESTMENTS, INC.	0%	0	-	-3	-100.00%
Dec 31, 2023	QUBE RESEARCH & TECHNOLOGIES LTD	0%	4	3	0	0
Dec 31, 2023	WELLS FARGO & COMPANY/MN	0%	131	91	-1	-0.76%
Dec 31, 2023	MORGAN STANLEY	0%	219	151	0	0
Dec 31, 2023	JPMORGAN CHASE & CO	0%	668	462	0	0
Dec 31, 2023	BANQUE CANTONALE VAUDOISE	0.02%	3.9K	3K	0	0
Dec 31, 2023	TOWER RESEARCH CAPITAL LLC (TRC)	0.03%	8.45K	5.84K	1.19K	+16.34%
Dec 31, 2023	TWO SIGMA INVESTMENTS, LP	0.04%	10.18K	7.04K	-700	-6.44%
Dec 31, 2023	DEUTERIUM CAPITAL MANAGEMENT, LLC	0.04%	11K	7.61K	0	0
Dec 31, 2023	RAYMOND JAMES & ASSOCIATES	0.05%	14K	9.69K	0	0
Dec 31, 2023		0.06%	14.85K	10.27K	14.85K	+100.00%
Dec 31, 2023	TWO SIGMA ADVISERS, LP	0.07%	19K	13.15K	-400	-2.06%
Dec 31, 2023	STATE STREET CORP	0.1%	25.77K	17.84K	0	0
Dec 31, 2023	CITADEL ADVISORS LLC	0.1%	25.8K	17.86K	25.8K	+100.00%
Dec 31, 2023	NORTHERN TRUST CORP	0.1%	26.05K	18.03K	0	0
Dec 31, 2023	BLACKROCK INC.	0.14%	34.81K	24.09K	-412	-1.17%
Dec 31, 2023	MILLENNIUM MANAGEMENT LLC	0.15%	38.3K	26.5K	-19.01K	-33.18%
Dec 31, 2023	BANK OF AMERICA CORP /DE/	0.36%	90.79K	62.83K	14	+0.02%

Insiders

Among the SNSE insiders holding of 32.08% of the stake in company, RICKS THOMAS G, director, holds the largest shares of 341.77K. CAMBRIAN BIOPHARMA INC, 10 percent owner, is the second largest SNSE insider with ownership of 155.14K shares. PEYER JAMES, See remarks below, stands third with possession of 155.14K shares of that stake.

Insiders	Designation	Shares Held
RICKS THOMAS G	director	341.77K
CAMBRIAN BIOPHARMA INC	10 percent owner	155.14K
PEYER JAMES	See remarks below	155.14K
CELEBI JOHN	President and CEO	111.31K
PIERCE ROBERT HAMILTON	Chief Scientific Officer	0
APEIRON INVESTMENT GROUP LTD.	10 percent owner	0

Buying/Selling by Insiders

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Dec 09, 2025	CAMBRIAN BIOPHARMA INC	SALE	7.92	446	3.53K	155.14K
Dec 09, 2025	PEYER JAMES	SALE	7.92	446	3.53K	155.14K
Dec 08, 2025	PEYER JAMES	SALE	8.59	3.11K	26.67K	158.25K
Dec 05, 2025	CAMBRIAN BIOPHARMA INC	SALE	13.16	42	552.72	161.36K
Dec 05, 2025	PEYER JAMES	SALE	13.16	42	552.72	161.36K
Dec 04, 2025	PEYER JAMES	SALE	9.06	5K	45.3K	177.65K
Dec 04, 2025	CAMBRIAN BIOPHARMA INC	SALE	9.06	5K	45.3K	177.65K
Sep 11, 2023	CELEBI JOHN	PURCHASE	0.85	500	425	111.31K
Jun 01, 2023	APEIRON INVESTMENT GROUP LTD.	SALE	1.58	955.74K	1.51M	0
Feb 23, 2023	APEIRON INVESTMENT GROUP LTD.	PURCHASE	1.61	1.1K	1.78K	2.48M
Mar 02, 2022	CAMBRIAN BIOPHARMA INC	PURCHASE	3.20	1.2K	3.85K	5.23M
Mar 02, 2022	PEYER JAMES	PURCHASE	3.20	1.2K	3.85K	5.23M
Mar 01, 2022	CAMBRIAN BIOPHARMA INC	PURCHASE	3.60	2.46K	8.85K	5.23M
Mar 01, 2022	PEYER JAMES	PURCHASE	3.60	2.46K	8.85K	5.23M
Feb 28, 2022	PEYER JAMES	PURCHASE	3.60	42	151.2	5.23M
Feb 28, 2022	CAMBRIAN BIOPHARMA INC	PURCHASE	3.60	42	151.2	5.23M
Feb 25, 2022	PEYER JAMES	PURCHASE	3.65	2.5K	9.13K	5.23M
Feb 25, 2022	CAMBRIAN BIOPHARMA INC	PURCHASE	3.65	2.5K	9.13K	5.23M
Feb 24, 2022	CAMBRIAN BIOPHARMA INC	PURCHASE	3.63	15K	54.45K	5.23M
Feb 24, 2022	PEYER JAMES	PURCHASE	3.63	15K	54.45K	5.23M
Feb 23, 2022	PEYER JAMES	PURCHASE	3.80	2.5K	9.5K	5.21M
Feb 23, 2022	CAMBRIAN BIOPHARMA INC	PURCHASE	3.80	2.5K	9.5K	5.21M
Feb 18, 2022	PEYER JAMES	PURCHASE	3.97	15K	59.55K	5.21M
Feb 18, 2022	CAMBRIAN BIOPHARMA INC	PURCHASE	3.97	15K	59.55K	5.21M
Feb 17, 2022	PEYER JAMES	PURCHASE	4.17	4.95K	20.64K	5.19M
Feb 17, 2022	CAMBRIAN BIOPHARMA INC	PURCHASE	4.17	4.95K	20.64K	5.19M
Feb 16, 2022	CAMBRIAN BIOPHARMA INC	PURCHASE	4.25	2.55K	10.84K	5.19M
Feb 16, 2022	PEYER JAMES	PURCHASE	4.25	2.55K	10.84K	5.19M
Feb 14, 2022	PEYER JAMES	PURCHASE	4.18	10K	41.8K	5.19M
Feb 14, 2022	CAMBRIAN BIOPHARMA INC	PURCHASE	4.18	10K	41.8K	5.19M
Feb 11, 2022	PEYER JAMES	PURCHASE	4.40	12.5K	55K	5.18M
Feb 11, 2022	CAMBRIAN BIOPHARMA INC	PURCHASE	4.40	12.5K	55K	5.18M
Feb 10, 2022	PEYER JAMES	PURCHASE	4.58	5K	22.9K	5.16M
Feb 10, 2022	CAMBRIAN BIOPHARMA INC	PURCHASE	4.58	5K	22.9K	5.16M
Feb 08, 2022	PEYER JAMES	PURCHASE	4.33	10K	43.3K	5.16M
Feb 08, 2022	CAMBRIAN BIOPHARMA INC	PURCHASE	4.33	10K	43.3K	5.16M
Feb 04, 2022	PEYER JAMES	PURCHASE	4.45	2.5K	11.13K	5.15M
Feb 04, 2022	CAMBRIAN BIOPHARMA INC	PURCHASE	4.45	2.5K	11.13K	5.15M
Feb 03, 2022	PEYER JAMES	PURCHASE	4.65	17.5K	81.38K	5.15M
Feb 03, 2022	CAMBRIAN BIOPHARMA INC	PURCHASE	4.65	17.5K	81.38K	5.15M
Jan 28, 2022	PEYER JAMES	PURCHASE	4.22	8.9K	37.56K	5.13M
Jan 28, 2022	CAMBRIAN BIOPHARMA INC	PURCHASE	4.22	8.9K	37.56K	5.13M
Jan 27, 2022	PEYER JAMES	PURCHASE	4.31	6.1K	26.29K	5.12M
Jan 27, 2022	CAMBRIAN BIOPHARMA INC	PURCHASE	4.31	6.1K	26.29K	5.12M
Jan 26, 2022	PEYER JAMES	PURCHASE	4.62	29.9K	138.14K	5.11M
Jan 26, 2022	CAMBRIAN BIOPHARMA INC	PURCHASE	4.62	29.9K	138.14K	5.11M
Jan 25, 2022	CAMBRIAN BIOPHARMA INC	PURCHASE	4.86	20.1K	97.69K	5.08M
Jan 25, 2022	PEYER JAMES	PURCHASE	4.86	20.1K	97.69K	5.08M
Jan 24, 2022	CAMBRIAN BIOPHARMA INC	PURCHASE	4.69	22.71K	106.5K	5.06M
Jan 24, 2022	PEYER JAMES	PURCHASE	4.69	22.71K	106.5K	5.06M
Jan 21, 2022	PEYER JAMES	PURCHASE	4.94	24.7K	122.03K	5.04M
Jan 21, 2022	CAMBRIAN BIOPHARMA INC	PURCHASE	4.94	24.7K	122.03K	5.04M
Jan 20, 2022	PEYER JAMES	PURCHASE	5.17	20K	103.4K	5.02M
Jan 20, 2022	CAMBRIAN BIOPHARMA INC	PURCHASE	5.17	20K	103.4K	5.02M
Jan 19, 2022	PEYER JAMES	PURCHASE	4.97	10.24K	50.91K	5M
Jan 19, 2022	CAMBRIAN BIOPHARMA INC	PURCHASE	4.97	10.24K	50.91K	5M
Jan 18, 2022	CAMBRIAN BIOPHARMA INC	PURCHASE	5.08	10K	50.8K	4.99M
Jan 18, 2022	PEYER JAMES	PURCHASE	5.08	10K	50.8K	4.99M
Jan 14, 2022	PEYER JAMES	PURCHASE	4.99	6.22K	31.03K	4.98M
Jan 14, 2022	CAMBRIAN BIOPHARMA INC	PURCHASE	4.99	6.22K	31.03K	4.98M
Jan 13, 2022	CAMBRIAN BIOPHARMA INC	PURCHASE	5.13	19.95K	102.36K	4.97M
Jan 13, 2022	PEYER JAMES	PURCHASE	5.13	19.95K	102.36K	4.97M
Jan 12, 2022	CAMBRIAN BIOPHARMA INC	PURCHASE	5.22	9.2K	48.03K	4.95M
Jan 12, 2022	PEYER JAMES	PURCHASE	5.22	9.2K	48.03K	4.95M
Jan 11, 2022	CAMBRIAN BIOPHARMA INC	PURCHASE	5.18	10.85K	56.18K	4.94M
Jan 11, 2022	PEYER JAMES	PURCHASE	5.18	10.85K	56.18K	4.94M
Jan 10, 2022	PEYER JAMES	PURCHASE	5.28	10K	52.8K	4.93M
Jan 10, 2022	CAMBRIAN BIOPHARMA INC	PURCHASE	5.28	10K	52.8K	4.93M
Dec 30, 2021	CAMBRIAN BIOPHARMA INC	PURCHASE	4.85	1.13K	5.47K	4.92M
Dec 30, 2021	PEYER JAMES	PURCHASE	4.85	1.13K	5.47K	4.92M
Dec 29, 2021	PEYER JAMES	PURCHASE	4.98	69K	343.62K	4.92M
Dec 29, 2021	CAMBRIAN BIOPHARMA INC	PURCHASE	4.98	69K	343.62K	4.92M
Dec 28, 2021	CAMBRIAN BIOPHARMA INC	PURCHASE	5.28	11.29K	59.6K	4.85M
Dec 28, 2021	PEYER JAMES	PURCHASE	5.28	11.29K	59.6K	4.85M
Dec 27, 2021	PEYER JAMES	PURCHASE	5.30	3.71K	19.67K	4.84M
Dec 27, 2021	CAMBRIAN BIOPHARMA INC	PURCHASE	5.30	3.71K	19.67K	4.84M
Dec 23, 2021	CAMBRIAN BIOPHARMA INC	PURCHASE	5.27	11K	57.97K	4.83M
Dec 23, 2021	PEYER JAMES	PURCHASE	5.27	11K	57.97K	4.83M
Dec 17, 2021	PEYER JAMES	PURCHASE	5.29	117	618.93	4.82M
Dec 17, 2021	CAMBRIAN BIOPHARMA INC	PURCHASE	5.29	117	618.93	4.82M
Dec 16, 2021	PEYER JAMES	PURCHASE	5.25	10.93K	57.36K	4.82M
Dec 16, 2021	CAMBRIAN BIOPHARMA INC	PURCHASE	5.25	10.93K	57.36K	4.82M
Dec 10, 2021	RICKS THOMAS G	PURCHASE	5.86	20K	117.2K	341.77K
Dec 09, 2021	RICKS THOMAS G	PURCHASE	6.62	20K	132.4K	321.77K
Aug 11, 2021	PIERCE ROBERT HAMILTON	SALE	7.34	16.03K	117.72K	0
Aug 10, 2021	PIERCE ROBERT HAMILTON	SALE	7.13	66.35K	473K	16.03K
Aug 09, 2021	PIERCE ROBERT HAMILTON	SALE	7.06	6.98K	49.3K	82.38K
Aug 06, 2021	PIERCE ROBERT HAMILTON	SALE	7.11	6.46K	45.95K	89.36K
May 05, 2021	CAMBRIAN BIOPHARMA INC	PURCHASE	12.00	350	4.2K	4.81M
May 05, 2021	PEYER JAMES	PURCHASE	12.00	350	4.2K	4.81M
Apr 20, 2021	PEYER JAMES	PURCHASE	12.77	385	4.92K	4.81M
Apr 20, 2021	CAMBRIAN BIOPHARMA INC	PURCHASE	12.77	385	4.92K	4.81M
Apr 19, 2021	CAMBRIAN BIOPHARMA INC	PURCHASE	13.38	1.97K	26.29K	4.81M
Apr 19, 2021	PEYER JAMES	PURCHASE	13.38	1.97K	26.29K	4.81M
Apr 13, 2021	CAMBRIAN BIOPHARMA INC	PURCHASE	14.00	2K	28K	4.81M
Apr 13, 2021	PEYER JAMES	PURCHASE	14.00	2K	28K	4.81M
Apr 07, 2021	CAMBRIAN BIOPHARMA INC	PURCHASE	14.00	2K	28K	4.81M
Apr 07, 2021	PEYER JAMES	PURCHASE	14.00	2K	28K	4.81M
Apr 01, 2021	CAMBRIAN BIOPHARMA INC	PURCHASE	14.00	1K	14K	4.81M
Apr 01, 2021	PEYER JAMES	PURCHASE	14.00	1K	14K	4.81M
Mar 23, 2021	CAMBRIAN BIOPHARMA INC	PURCHASE	14.34	9.5K	136.23K	4.8M
Mar 23, 2021	PEYER JAMES	PURCHASE	14.34	9.5K	136.23K	4.8M
Feb 18, 2021	PEYER JAMES	PURCHASE	19.75	752	14.85K	4.69M
Feb 18, 2021	CAMBRIAN BIOPHARMA INC	PURCHASE	19.75	752	14.85K	4.69M

Insider Transaction Summary (6 Months)

SHARESTRANS

PURCHASE00

SALES14.08K7

NET SHARES-14.08K7

SHARES HELD1.15M7

% NET SHARES-101.23%0%

Frequently Asked Questions